The Iron Chelators Dp44mT and DFO Inhibit TGF-β-induced Epithelial-Mesenchymal Transition via Up-Regulation of N-Myc Downstream-regulated Gene 1 (NDRG1)
Top Cited Papers
Open Access
- 18 May 2012
- journal article
- Published by Elsevier BV
- Vol. 287 (21), 17016-17028
- https://doi.org/10.1074/jbc.m112.350470
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferationBlood, 2004
- N-Myc Downregulated Gene 1 Is a Phosphorylated Protein in Mast CellsBiological & Pharmaceutical Bulletin, 2004
- The effect of potent iron chelators on the regulation of p53: examination of the expression, localization and DNA-binding activity of p53 and the transactivation of WAF1Carcinogenesis: Integrative Cancer Research, 2003
- The involvement of hypoxia-inducible transcription factor-1-dependent pathway in nickel carcinogenesis.2003
- The Drg-1 gene suppresses tumor metastasis in prostate cancer.2003
- Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation.2001
- Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer.2000
- TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors.The Journal of cell biology, 1994
- G1 phase progression: Cycling on cueCell, 1994
- The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell.1994